DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C0011615 | Dermatitis, Atopic | PLA2G2E | 30814 | phospholipase A2 group IIE | Q9NZK7 |
C0007102 | Malignant tumor of colon | PLA2G3 | 50487 | phospholipase A2 group III | Q9NZ20 |
C1306459 | Primary malignant neoplasm | PLA2G3 | 50487 | phospholipase A2 group III | Q9NZ20 |
C0699790 | Colon Carcinoma | PLA2G3 | 50487 | phospholipase A2 group III | Q9NZ20 |
C0027051 | Myocardial Infarction | PLA2G3 | 50487 | phospholipase A2 group III | Q9NZ20 |
C0027651 | Neoplasms | PLA2G3 | 50487 | phospholipase A2 group III | Q9NZ20 |
C0684249 | Carcinoma of lung | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C0006142 | Malignant neoplasm of breast | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C0027651 | Neoplasms | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C0036341 | Schizophrenia | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C0025517 | Metabolic Diseases | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C4048328 | cervical cancer | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C0002736 | Amyotrophic Lateral Sclerosis | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C0004153 | Atherosclerosis | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C0005586 | Bipolar Disorder | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C0334590 | Anaplastic Oligodendroglioma | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C0014335 | Enteritis | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C1956346 | Coronary Artery Disease | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C0036337 | Schizoaffective Disorder | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C0014544 | Epilepsy | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C0042109 | Urticaria | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C1306459 | Primary malignant neoplasm | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C0242379 | Malignant neoplasm of lung | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C0740391 | Middle Cerebral Artery Occlusion | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
C0010674 | Cystic Fibrosis | PLA2G4A | 5321 | phospholipase A2 group IVA | P47712 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024